Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
Conditions: Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Hospital Israelita Albert Einstein; AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Brazil Health | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | Hospitals | Research